PARI Medical Holding GMBH - Company & Market Research Reports

Pari Pharma is a pharmaceutical company that focuses on innovating respiratory products and services to improve the lives of those suffering from respiratory diseases. The company PARItec GmbH emerged in 1999 from the merger of Pari's own production operations.The corporate headquarters is Starnberg; production facilities are located in Weilheim. Their main focus is the production of inhalation devices and efficient nebuliser systems for the PARI corporate group.Pari Pharma is now a global company with companies in the U.S.A, Russia, Japan, the United Kingdom etc.

Global Nebulizer Market 2017-2021 - Product Thumbnail Image

Global Nebulizer Market 2017-2021

  • Report
  • 93 Pages
From
Global Nebulizers Market 2016-2020 - Product Thumbnail Image

Global Nebulizers Market 2016-2020

  • Report
  • 56 Pages
From
Global Pneumatic Nebulizers Market 2016-2020 - Product Thumbnail Image

Global Pneumatic Nebulizers Market 2016-2020

  • Report
  • 64 Pages
From
Respiratory Care Equipment and Supplies - Global Strategic Business Report - Product Thumbnail Image

Respiratory Care Equipment and Supplies - Global Strategic Business Report

  • Report
  • 502 Pages
From
Asthma: Market Intelligence Review and Insights - Product Thumbnail Image

Asthma: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Global Self-care Medical Devices 2016-2020 - Product Thumbnail Image

Global Self-care Medical Devices 2016-2020

  • Report
  • 106 Pages
From
Alzheimer's: Pipeline Assessment and Insights - Product Thumbnail Image

Alzheimer's: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Alzheimer's Disease: Market Intelligence Review and Insights - Product Thumbnail Image

Alzheimer's Disease: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Cystic Fibrosis: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Cystic Fibrosis: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Asthma: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Asthma: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Asthma: Pipeline Assessment and Insights - Product Thumbnail Image

Asthma: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Asthma: Epidemiology Overview and Insights - Product Thumbnail Image

Asthma: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
COPD: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

COPD: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Cystic Fibrosis: Epidemiology Overview and Insights - Product Thumbnail Image

Cystic Fibrosis: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
COPD: Epidemiology Overview and Insights - Product Thumbnail Image

COPD: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
COPD: Market Intelligence Review and Insights - Product Thumbnail Image

COPD: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Pseudomonas Infections Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pseudomonas Infections Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 126 Pages
From
Pseudomonas aeruginosa Infections Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pseudomonas aeruginosa Infections Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 117 Pages
From
Bronchiolitis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Bronchiolitis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 118 Pages
From
Loading Indicator
adroll